Opioid Induced Constipation Drugs Market Outlook, Dynamics and Strategic Insights by 2031

MARKET INTRODUCTION

Opioid drugs are known to inhibit gastric emptying and peristalsis in the GI tract which results in delayed absorption of medications and increased absorption of fluid. The lack of fluid in the intestine leads to hardening of stool and constipation. Most patients with OIC complain of straining and incomplete emptying of the rectum during defecation. Opioids also increase anal sphincter tone impairing the defecation reflex. Anal sphincter dysfunction is important to note in patients experiencing anal blockage. Moreover, opioids have been found to decrease emptying of pancreatic juice and bile leading to delayed digestion. Opioid-induced constipation (OIC) accounts for more than 40% to 60% of noncancerous patients receiving opioids.

MARKET DYNAMICS

Opioid Induced Constipation Drugs market is driving due to factors such as alarming growth in opioid prescription for non-cancer pain and increasing prevalence of opioid induced constipation. However, factors such as, lack of awareness about OIC among the patients and rising preference for general laxatives and ongoing research activities to develop next-generation analgesics to replace opioids is expected to hamper the market growth.

MARKET SCOPE

The Opioid Induced Constipation Drugs market analysis to 2031 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Opioid Induced Constipation Drugs market with detailed market segmentation by drug type and prescription type. The Opioid Induced Constipation Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Opioid Induced Constipation Drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Opioid Induced Constipation Drugs market is segmented on the basis of drug type and prescription type. Based on drug type, the market is segmented as Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Naldemedine, Docusate Sodium, Others. Based on prescription type, market is segmented as prescribed drugs, over the counter drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Opioid Induced Constipation Drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Induced Constipation Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Opioid Induced Constipation Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Induced Constipation Drugs market in these regions.

MARKET PLAYERS

The report covers key developments in the Opioid Induced Constipation Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Opioid Induced Constipation Drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Opioid Induced Constipation Drugs in the global market. Below mentioned is the list of few companies engaged in the Opioid Induced Constipation Drugs market.
The report also includes the profiles of key players in Opioid Induced Constipation Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  AstraZeneca plc.
  
•  Mallinckrodt Pharmaceuticals
  
•  Salix Pharmaceuticals Inc.
  
•  Merck & Co Inc.
  
•  Shionogi & Co Ltd.
  
•  Ironwood Pharmaceutical Inc.
  
•  Pfizer
  
•  Progenics Pharmaceuticals Inc.
  
•  Nektar Therapeutics
  
•  Purdue Pharma
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Opioid Induced Constipation Drugs Report Scope